Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
Open Access
- 20 January 2022
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 38 (4), 336-346
- https://doi.org/10.1002/kjm2.12499
Abstract
The current study set out to clarify the role of miR-424-5p promoter methylation in epithelial mesenchymal transition (EMT) of hepatocellular carcinoma (HCC) cells. The findings of quantitative real-time-polymerase chain reaction and methylation-sensitive high-resolution melting assays elicited that miR-424-5p was poorly expressed in HCC tissues and cells while highly methylated. Meanwhile, upon demethylation, miR-424-5p expression levels were partly recovered in HCC cells. In addition, miR-424-5p upregulation reduced cell viability and elevated apoptosis of HCC cells, in parallel with increased N-cadherin and decreased E-cadherin levels. Dual-luciferase reporter assay further validated that miR-424-5p bound to the kinesin family member 2A (KIF2A), and miR-424-5p overexpression downregulated KIF2A. In addition, KIF2A overexpression reversed the miR-424-5p-driven changes in terms of cell viability, apoptosis and EMT-related protein levels. Furthermore, xenograft tumors were established via injection of Huh7 cells, followed by miR-424-5p overexpression in vivo, which inhabited KIF2A downregulation and attenuated tumor growth along with decreased Ki67 positive expression, diminished N-cadherin and elevated E-cadherin levels. Overall, our findings supported the conclusion that miR-424-5p promoter methylation reduced miR-424-5p expression and upregulated KIF2A, thereby promoting HCC EMT.Keywords
This publication has 38 references indexed in Scilit:
- Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular CarcinomaCurrent Cancer Drug Targets, 2017
- Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinomaJournal of Cancer Research and Therapeutics, 2017
- Meta-analysis of DNA methylation biomarkers in hepatocellular carcinomaOncotarget, 2016
- Immunotherapy for hepatocellular carcinomaDrug Discoveries & Therapeutics, 2015
- Kinesin superfamily proteins and the regulation of microtubule dynamics in morphogenesisAnatomical Science International, 2014
- MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progressionScientific Reports, 2014
- DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinomaWorld Journal of Gastroenterology, 2014
- Epigenetics of hepatocellular carcinoma: Role of microRNAWorld Journal of Gastroenterology, 2013
- DNA Methylation and Its Basic FunctionNeuropsychopharmacology, 2012
- DNA methylation of tumor suppressor miRNA genes: a lesson from themiR-34familyEpigenomics, 2011